171
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Uveitis Patterns and Severity: An Epidemiologic Study from a Tertiary Care Private Referral Center in Buenos Aires, Argentina

, MD, , MD, , MD, , MDCM, PhD, FRCSCORCID Icon & , MD, PhD
Pages 710-716 | Received 08 Jun 2021, Accepted 04 Mar 2022, Published online: 11 Apr 2022

References

  • de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30(6):452–470. doi:10.1016/j.preteyeres.2011.06.005.
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.
  • Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013;131(11):1405–1412. doi:10.1001/jamaophthalmol.2013.4237.
  • Nelson WW, Rice JB, White AG, et al. Predictors of high-cost patients with noninfectious inflammatory eye diseases. Clin Ther. 2019;41(11):2331–2342. doi:10.1016/j.clinthera.2019.09.011.
  • Cordero-Coma M, Salazar-Mendez R, Yilmaz T. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues. Expert Opin Drug Saf. 2015;14(9):1353–1371. doi:10.1517/14740338.2015.1061992.
  • Cordero-Coma M, Salazar-Mendez R, Yilmaz T. Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues. Expert Opin Drug Saf. 2015;14(7):1071–1086. doi:10.1517/14740338.2015.1044969.
  • worldpopulationreview. https://worldpopulationreview.com/world-cities/buenos-aires-population. 2021 Accessed April 17th, 2021.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
  • Deschenes J, Murray PI, Rao NA, Nussenblatt RB. International uveitis study G. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1):1–2. doi:10.1080/09273940801899822.
  • Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for acute retinal necrosis syndrome. Am J Ophthalmol. 2021;228:237–244. doi:10.1016/j.ajo.2021.03.057.
  • Holland GN. The progressive outer retinal necrosis syndrome. Int Ophthalmol. 1994;18(3):163–165. doi:10.1007/BF00915966.
  • Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome–bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;151(2):198–216 e1. doi:10.1016/j.ajo.2010.10.018.
  • Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50(4):364–388. doi:10.1016/j.survophthal.2005.04.003.
  • Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm. 2011;19(2):139–144. doi:10.3109/09273948.2010.542269.
  • Dodds EM, Lowder CY, Meisler DM. Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics. Ocul Immunol Inflamm. 1999;7(2):85–92. doi:10.1076/ocii.7.2.85.4015.
  • Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2010;21(6):468–472. doi:10.1097/ICU.0b013e32833eab83.
  • Keenan JD, Tessler HH, Goldstein DA. Granulomatous inflammation in juvenile idiopathic arthritis-associated uveitis. J AAPOS. 2008;12(6):546–550. doi:10.1016/j.jaapos.2008.05.012.
  • Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm. 2013;21(3):180–191. doi:10.3109/09273948.2013.791701.
  • Jones NP. Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye (Lond). 1991;5(Pt 6):649–661. doi:10.1038/eye.1991.121.
  • Jones NP. Fuchs’ heterochromic uveitis: an update. Surv Ophthalmol. 1993;37(4):253–272. doi:10.1016/0039-6257(93)90009-V.
  • Beneyto P, Fernandez MJ, Garcia A, Ibanez M, Garcia-Aparicio A, Morente P. Fuchs’ heterochromic cyclitis without heterochromia: a diagnostic approach. Arch Soc Esp Oftalmol. 2007;82(6):355–359. doi:10.4321/s0365-66912007000600007.
  • Jap A, Sivakumar M, Chee SP. Is Posner Schlossman syndrome benign? Ophthalmology. 2001;108(5):913–918. doi:10.1016/S0161-6420(01)00551-6.
  • Green RJ. Posner-Schlossman syndrome (glaucomatocyclitic crisis). Clin Exp Optom. 2007;90(1):53–56. doi:10.1111/j.1444-0938.2006.00088.x.
  • Rodier-Bonifas C, Cornut PL, Billaud G, Lina B, Burillon C, Denis P. Cytomegalovirus research using polymerase chain reaction in Posner-Schlossman syndrome. J Fr Ophtalmol. 2011;34(1):24–29. doi:10.1016/j.jfo.2010.10.008.
  • Criteria for diagnosis of Behçet’s disease. International study group for Behçet’s disease. Lancet. 1990;335(8697):1078–1080.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652.
  • Herbort CP, Rao NA, Mochizuki M, Members of Scientific Committee of First International Workshop on Ocular S. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–169. doi:10.1080/09273940902818861.
  • Quillen DA, Davis JB, Gottlieb JL, et al. The white dot syndromes. Am J Ophthalmol. 2004;137(3):538–550. doi:10.1016/j.ajo.2004.01.053.
  • Crawford CM, Igboeli O. A review of the inflammatory chorioretinopathies: the white dot syndromes. ISRN Inflamm. 2013;2013:783190. doi:10.1155/2013/783190.
  • Yeh S, Forooghian F, Wong WT, et al. Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol. 2010;128(1):46–56. doi:10.1001/archophthalmol.2009.368.
  • Knickelbein JE, Sen HN. Multimodal imaging of the white dot syndromes and related diseases. J Clin Exp Ophthalmol. 2016; 7(3). doi: 10.4172/2155-9570.1000570.
  • Gupta A, Bansal R, Gupta V, Sharma A, Bambery P. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149(4):562–570. doi:10.1016/j.ajo.2009.11.020.
  • Dutton GN. Toxoplasmic retinochoroiditis–a historical review and current concepts. Ann Acad Med Singap. 1989;18:214–221.
  • Johnson MW, Greven GM, Jaffe GJ, Sudhalkar H, Vine AK. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology. 1997;104(1):48–57. doi:10.1016/S0161-6420(97)30362-5.
  • Fardeau C, Romand S, Rao NA, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 2002;134(2):196–203. doi:10.1016/S0002-9394(02)01500-3.
  • Robert-Gangneux F, Binisti P, Antonetti D, Brezin A, Yera H, Dupouy-Camet J. Usefulness of immunoblotting and Goldmann-Witmer coefficient for biological diagnosis of toxoplasmic retinochoroiditis. Eur J Clin Microbiol Infect Dis. 2004;23(1):34–38. doi:10.1007/s10096-003-1048-6.
  • Wong A, McKelvie J, Slight C, Sims J. Land of the long white cloud: the spectrum of uveitis at a tertiary referral center in New Zealand. Ocul Immunol Inflamm. 2017;25(sup1):S115–S21. doi:10.1080/09273948.2016.1203957.
  • Hart CT, Zhu EY, Crock C, Rogers SL, Lim LL. Epidemiology of uveitis in urban Australia. Clin Exp Ophthalmol. 2019;47(6):733–740. doi:10.1111/ceo.13517.
  • Devoto FJ. Argentine migration policy and movements of the European population (1876-1925). Estud Migr Latinoam. 1989;4:135–158.
  • Llorenc V, Mesquida M, Sainz de la Maza M, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93(6):561–567. doi:10.1111/aos.12675.
  • Liberman P, Gauro F, Berger O, Urzua CA. Causes of uveitis in a tertiary center in Chile: a cross-sectional retrospective review. Ocul Immunol Inflamm. 2015;23(4):339–345. doi:10.3109/09273948.2014.981548.
  • Gonzalez Fernandez D, Nascimento H, Nascimento C, Muccioli C, Belfort R Jr. Uveitis in Sao Paulo, Brazil: 1053 new patients in 15 months. Ocul Immunol Inflamm. 2017;25(3):382–387. doi:10.3109/09273948.2015.1132741.
  • Caputo M, Amador MA, Sala A, Riveiro Dos Santos A, Santos S, Corach D. Ancestral genetic legacy of the extant population of Argentina as predicted by autosomal and X-chromosomal DIPs. Mol Genet Genomics. 2021;296:581–590. doi:10.1007/s00438-020-01755-w.
  • Arellanes-Garcia L, Bautista N, Mora P, Ortega-Larrocea G, Burguet A, Gorodezky C. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm. 1998;6(2):93–100. doi:10.1076/ocii.6.2.93.4049.
  • Kryshtalskyj MT, Roy M. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population. Ocul Immunol Inflamm. 2021;1–7. doi:10.1080/09273948.2020.1849737.
  • Roy M. Analysis of uveitis in a Canadian aboriginal population. Can J Ophthalmol. 2014;49(2):128–134. doi:10.1016/j.jcjo.2013.09.020.
  • Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–220. doi:10.1034/j.1399-0039.1999.540301.x.
  • Arbesfeld SJ, Kurban AK. Behcet’s disease. New perspectives on an enigmatic syndrome. J Am Acad Dermatol. 1988;19(5 Pt 1):767–779. doi:10.1016/S0190-9622(88)70233-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.